The Eli Lilly-backed biosimilar drug developer has now taken in more than $220m in funding.

The cardiac drug maker has set a $15m target for the round, and has now raised about $110m altogether

Proteon Therapeutics secured $45m from a series D round that has increased its overall funding to approximately $126.5m.

Accelevate will seek to encourage digital healthcare innovation with a new team for venture capital and health market expertise.

Sleep disorder treatment company Inspire Medical Systems, also backed by Johnson & Johnson, has secured $40m from its series E round.

The Novo-backed company, which is developing a treatment for hyperkalemia, will use the proceeds to support its clinical programme.

STF Technologies is developing a puncture-resistant glove.

Robert Plehn has left financial services firm Lloyds to head up General Electric subsidiary GE Capital's capital markets team.

Chase Pharmaceuticals will use the financing raised in the series B round to advance its Alzheimer's treatment.